Pulmonary Disease Requiring Ambulatory Oxygen Therapy -Resilience and Quality of Life

NCT04554225 | Unknown

• 1 other identifier: 507A023
• Study Type: observational
• Target: 43
• Locations: 1 country
• Sites: 1

Brief Summary

Dyspnea is common symptom in pulmonary diseases, like chronic obstructive pulmonary disease (COPD) or other pulmonary disease. Ambulatory oxygen therapy is often prescribed to these patients. In these patients resilience, health related quality of life, life satisfaction are measured and the effect and patient satisfaction to ambulatory oxygen therapy are studied.

Conditions

Pulmonary Disease

Keywords

resilience; psychological; quality of life; oxygen inhalation therapy; lung diseases

Outcome Measures

Primary Outcomes (2)

• Health related quality of life

  15-D - health related quality of life measurement (0= the worst quality of life, 1= the best quality of life)

  Baseline (Before start of ambulatory oxygen therapy)

• Health related quality of life

  15-D - health related quality of life measurement (0=the worst quality of life, 1= the best quality of life)

  At 24 months

Secondary Outcomes (9)

• Life satisfaction

  Baseline (Before start of ambulatory oxygen therapy)

• Life satisfaction

  At 24 months

• Usability of ambulatory oxygen

  At one month

• Anxiety

  Baseline (Before start of ambulatory oxygen therapy)

• Anxiety

  24 months

Study Arms (1)

Pulmonary disease patients

Patients with COPD or other pulmonary disease starting to use ambulatory oxygen therapy

Drug: Oxygen gas

Interventions

Oxygen gas DRUG

Oxygen administered to a patient using ambulatory oxygen

Also known as: ambulatory oxygen

Pulmonary disease patients

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients with pulmonary disease who start or use ambulatory oxygen therapy

You may qualify if:

• Patient with pulmonary disease (e.g. COPD) who has ambulatory oxygen
• Patient with pulmonary disease (e.g. COPD) who is starting to use ambulatory oxygen
• Adult patient
• Informed consent of the patient received

You may not qualify if:

• Ambulatory oxygen prescribe for treatment of other than pulmonary disease.
• Age less than 18 years
• Dementia or other cognitive impairment that disables understanding of the study
• No informed consent

Sponsors & Collaborators

• Kuopio University Hospital: lead
• Helsinki University Central Hospital: collaborator
• Tampere University Hospital: collaborator

Study Sites (1)

Kuopio University Hospital

Kuopio, Northern Savonia, 70029, Finland

Location

Related Publications (2)

• Isokaanta S, Kokki H, Sintonen H, Kokki M. Resilience and health-related quality of life in patients with pulmonary diseases receiving ambulatory oxygen therapy - 24-month follow-up results. BMC Pulm Med. 2025 Jul 4;25(1):326. doi: 10.1186/s12890-025-03778-8.

  PMID: 40616033 DERIVED

• Isokaanta S, Honkalampi K, Kokki H, Sintonen H, Kokki M. Resilience and health-related quality of life in patients with pulmonary diseases receiving ambulatory oxygen therapy. BMC Pulm Med. 2021 May 1;21(1):144. doi: 10.1186/s12890-021-01515-5.

  PMID: 33933036 DERIVED

MeSH Terms

Conditions

Lung Diseases

Interventions

nitrox

Condition Hierarchy (Ancestors)

Respiratory Tract Diseases

Study Officials

• Merja Kokki, V

  Kuopio University Hospital

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: August 26, 2020
• First Posted: September 18, 2020
• Study Start: November 1, 2017
• Primary Completion: July 29, 2022
• Study Completion: December 31, 2023
• Last Updated: October 26, 2023

Record last verified: 2023-03

Data Sharing

• IPD Sharing: Will not share

Locations

FI (1)